EcoDrugPlus

Ensembl ID : ENSCMIG00000006280
Gene Symbol: -
Cross references: -
125 Possible Orthologues:

Ensembl ID : ENSCMIG00000010233
Gene Symbol: -
Cross references: -
204 Possible Orthologues:

Ensembl ID : ENSCMIG00000006767
Gene Symbol: -
Cross references: -
275 Possible Orthologues:

Ensembl ID : ENSCMIG00000007436
Gene Symbol: -
Cross references: -
156 Possible Orthologues:

Ensembl ID : ENSCMIG00000013299
Gene Symbol: -
Cross references: -
362 Possible Orthologues:

Ensembl ID : ENSCMIG00000015603
Gene Symbol: -
Cross references: -
264 Possible Orthologues:

Ensembl ID : ENSCMIG00000008846
Gene Symbol: RPS8A
1 Cross references
331 Possible Orthologues:

Ensembl ID : ENSCMIG00000016688
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSCMIG00000016753
Gene Symbol: -
Cross references: -
238 Possible Orthologues:

Ensembl ID : ENSCMIG00000006948
Gene Symbol: -
Cross references: -
223 Possible Orthologues:

Ensembl ID : ENSCMIG00000005083
Gene Symbol: -
Cross references: -
223 Possible Orthologues:

Ensembl ID : ENSCMIG00000002503
Gene Symbol: -
Cross references: -
223 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).